CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Dialysis patient service revenues	$ 2,951,950	$ 2,846,494	$ 8,602,669	$ 8,372,874
Other revenues	169,382	102,200	391,731	320,132
Total revenues	3,121,332	2,948,694	8,994,400	8,693,006
Operating expenses:
Patient care costs	2,067,315	2,085,555	6,181,348	6,120,872
General and administrative	376,883	365,447	1,072,513	975,486
Depreciation and amortization	188,423	194,414	550,166	538,534
Equity investment income, net	(7,228)	(8,509)	(22,502)	(24,696)
Total operating expenses	2,625,393	2,636,907	7,781,525	7,610,196
Operating income	495,939	311,787	1,212,875	1,082,810
Debt expense	(98,080)	(99,680)	(302,361)	(256,057)
Debt Extinguishment And Modification Costs	0	0	7,962	0
Other loss, net	(19,650)	(4,898)	(14,525)	(7,968)
Income before income taxes	378,209	207,209	888,027	818,785
Income tax expense	68,848	42,515	161,621	163,757
Net income	309,361	164,694	726,406	655,028
Less: Net income attributable to noncontrolling interests	(62,729)	(59,328)	(185,536)	(162,731)
Net income attributable to DaVita Inc.	$ 246,632	$ 105,366	$ 540,870	$ 492,297
Earnings per share attributable to DaVita Inc.:
Basic net income	$ 2.70	$ 1.16	$ 5.95	$ 5.24
Diluted net income	$ 2.62	$ 1.13	$ 5.80	$ 5.07
Weighted average shares for earnings per share:
Basic shares	91,322,000	91,160,000	90,937,000	93,959,000
Diluted shares	94,041,000	93,263,000	93,317,000	97,153,000